Insider Transactions in Q2 2022 at Magenta Therapeutics, Inc. (MGTA)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 31
2022
|
Thomas W. Beetham Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+15.08%
|
$0
$0.99 P/Share
|
|
May 31
2022
|
Jason Gardner Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+1.02%
|
$0
$0.99 P/Share
|
|
May 31
2022
|
Caren Deardorf Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+15.18%
|
$0
$0.99 P/Share
|
|
May 31
2022
|
Kristen Stants Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+14.8%
|
$0
$0.99 P/Share
|